Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Suzuki

Showing results (511-520 of 611) with videos related to

Pageof 62
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2000
11C-labeled KF18446: a potential central nervous system adenosine A2a receptor ligandK Ishiwata, J Noguchi, S Wakabayashi, et al.
Journal of Gastroenterology|June 1, 2000
Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinomaK Ikeda, S Saitoh, M Kobayashi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 1, 1992
[Evaluation of diet of calcium stone patients]H Ito, T Kotake, H Hayashi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 7, 1998
Evaluation of carbon-11-labeled KF17837: a potential CNS adenosine A2a receptor ligandJ Noguchi, K Ishiwata, S Wakabayashi, et al.
The Journal of Biological Chemistry|June 24, 1994
Changes in parathyroid hormone receptors during chondrocyte cytodifferentiationM Iwamoto, A Jikko, H Murakami, et al.
Japanese Journal of Pharmacology|June 30, 2000
L-DOPA cyclohexyl ester is a novel potent and relatively stable competitive antagonist against L-DOPA among several L-DOPA ester compoundsN Furukawa, Y Goshima, T Miyamae, et al.
Journal of Gastroenterology|June 29, 2001
Incidence of the appearance of the red color sign on esophageal varices and its predictive factors: long-term observations of 359 patients with cirrhosisN Murachima, K Ikeda, M Kobayashi, et al.
Journal of Gastroenterology and Hepatology|May 17, 2001
Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: a pilot studyK Ikeda, S Saitoh, M Kobayashi, et al.
Nihon Jinzo Gakkai Shi|October 1, 1991
[Clinical analysis of 35 patients with renal injury]T Kotake, N Miura, T Ueda, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|May 1, 1996
Synthesis and preliminary evaluation of [11C]KF17837, a selective adenosine A2A antagonistK Ishiwata, J Noguchi, H Toyama, et al.
Pageof 62

Showing results (511-520 of 611) with videos related to

Sort By:
Pageof 62
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2000
11C-labeled KF18446: a potential central nervous system adenosine A2a receptor ligandK Ishiwata, J Noguchi, S Wakabayashi, et al.
Journal of Gastroenterology|June 1, 2000
Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinomaK Ikeda, S Saitoh, M Kobayashi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 1, 1992
[Evaluation of diet of calcium stone patients]H Ito, T Kotake, H Hayashi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 7, 1998
Evaluation of carbon-11-labeled KF17837: a potential CNS adenosine A2a receptor ligandJ Noguchi, K Ishiwata, S Wakabayashi, et al.
The Journal of Biological Chemistry|June 24, 1994
Changes in parathyroid hormone receptors during chondrocyte cytodifferentiationM Iwamoto, A Jikko, H Murakami, et al.
Japanese Journal of Pharmacology|June 30, 2000
L-DOPA cyclohexyl ester is a novel potent and relatively stable competitive antagonist against L-DOPA among several L-DOPA ester compoundsN Furukawa, Y Goshima, T Miyamae, et al.
Journal of Gastroenterology|June 29, 2001
Incidence of the appearance of the red color sign on esophageal varices and its predictive factors: long-term observations of 359 patients with cirrhosisN Murachima, K Ikeda, M Kobayashi, et al.
Journal of Gastroenterology and Hepatology|May 17, 2001
Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: a pilot studyK Ikeda, S Saitoh, M Kobayashi, et al.
Nihon Jinzo Gakkai Shi|October 1, 1991
[Clinical analysis of 35 patients with renal injury]T Kotake, N Miura, T Ueda, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|May 1, 1996
Synthesis and preliminary evaluation of [11C]KF17837, a selective adenosine A2A antagonistK Ishiwata, J Noguchi, H Toyama, et al.
Pageof 62